Shweta Dang – författare

This book is a comprehensive coverage of the transformative role of nanotechnology in the field of biopharmaceuticals. The book covers the fundamental principles of nanotechnology and systematically explains how nanomaterials are revolutionizing drug delivery systems, formulation techniques, diagnostics, and imaging modalities. Through detailed discussions on lipid-based nanocarriers, polymeric nanoparticles, dendrimers, and nanogels, readers gain insights into the diverse array of nanomaterials and their applications in enhancing drug efficacy, targeting specific tissues, and minimizing adverse effects. Moreover, the book addresses critical aspects such as biocompatibility assessment, regulatory considerations, and ethical implications, underscoring the importance of responsible innovation in the development and commercialization of nano biopharmaceuticals. This book serves as an invaluable resource for researchers and practitioners to navigate the complex landscape of biopharmaceutical development. Through its interdisciplinary approach and forward-thinking perspectives on future trends and challenges, it contributes to shaping the future of healthcare by harnessing the power of nanotechnology to deliver innovative and effective therapeutics. The target audience for this book covers the fields of biopharmaceutical research, development, regulation, and policymaking. This includes scientists, researchers, and engineers seeking a deep understanding of nanotechnology's applications in drug delivery systems, formulation techniques, and diagnostic tools. Additionally, pharmaceutical industry professionals involved in drug development and manufacturing will find valuable insights into innovative nanoscale formulations and regulatory considerations. Overall, this book caters to a multidisciplinary audience seeking to leverage nanotechnologies for advancing biopharmaceutical research, development, and clinical practice.